Log in to save to my catalogue

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant...

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6028582

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies

About this item

Full title

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies

Publisher

London: Nature Publishing Group UK

Journal title

Cell research, 2018-07, Vol.28 (7), p.779-781

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Alternative Titles

Full title

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6028582

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6028582

Other Identifiers

ISSN

1001-0602

E-ISSN

1748-7838

DOI

10.1038/s41422-018-0055-1

How to access this item